EVLN | JFR | EVLN / JFR | |
Gain YTD | 3.265 | 2.232 | 146% |
Net Assets | 1.36B | 1.43B | 95% |
Total Expense Ratio | 0.60 | 1.99 | 30% |
Turnover | 32.00 | 38.00 | 84% |
Yield | 8.02 | 10.45 | 77% |
Fund Existence | 1 year | 21 years | - |
EVLN | JFR | |
---|---|---|
RSI ODDS (%) | 2 days ago6% | 2 days ago56% |
Stochastic ODDS (%) | N/A | 2 days ago63% |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | 2 days ago8% | 2 days ago87% |
TrendWeek ODDS (%) | 2 days ago22% | 2 days ago87% |
TrendMonth ODDS (%) | 2 days ago20% | 2 days ago85% |
Advances ODDS (%) | 5 days ago27% | 2 days ago86% |
Declines ODDS (%) | 25 days ago19% | 26 days ago62% |
BollingerBands ODDS (%) | 2 days ago5% | 2 days ago58% |
Aroon ODDS (%) | 2 days ago20% | 2 days ago84% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCTCX | 44.52 | N/A | N/A |
Goldman Sachs US Tax-Managed Eq C | |||
JIVRX | 29.47 | N/A | N/A |
JPMorgan U.S. Applied Data Sci Val R5 | |||
DGVRX | 85.02 | N/A | N/A |
BNY Mellon Technology Growth I | |||
ETNHX | 34.21 | N/A | N/A |
Eventide Healthcare & Life Sciences N | |||
NPFFX | 69.32 | -0.42 | -0.60% |
American Funds New Perspective F1 |